| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 36,340 | 29,628 | 17,393 | | Cost of Revenue | 10,935 | 9,015 | 7,820 | | | Gross Profit | 25,406 | 20,613 | 9,573 | | | Operating Expenses | | Research Development | 6,206 | 5,779 | 6,596 | | Selling General and Administrative | 21,412 | 17,937 | 14,003 | | Non Recurring |
-
|
-
|
-
| | Others | 5,045 | 5,006 | 134 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (7,257) | (8,108) | (11,160) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 199 | 1,762 | 1,064 | | Earnings Before Interest And Taxes | (7,058) | (6,346) | (10,096) | | Interest Expense | 7,882 | 7,946 | 2,516 | | Income Before Tax | (14,940) | (14,292) | (12,612) | | Income Tax Expense | (864) |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,077) | (14,292) | (12,612) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (14,077) | (14,292) | (12,612) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,077) | ($14,292) | ($12,612) |
|
0.07% Nasdaq 
0.01 (0.93%) 
Income Statement
